A response to the commentary « Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms » by Loftis, J.M. on « Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms »
Psychoneuroendocrinology. 2013-09-01; 38(9): 1830-1831
DOI: 10.1016/j.psyneuen.2013.05.019
Lire sur PubMed
1. Psychoneuroendocrinology. 2013 Sep;38(9):1830-1. doi:
10.1016/j.psyneuen.2013.05.019. Epub 2013 Jun 28.
A response to the commentary « Indolamine 2,3-dioxygenase regulation and
neuropsychiatric symptoms » by Loftis, J.M. on « Serotonin and interleukin-6: the
role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms » by Udina,
M., Moreno-España, J., Navinés, R., Gimenez, D., Langohr, K., Gratacòs, M.,
Capuron, L., de la Torre, R., Solà, R., Martin-Santos, R.
http:\dx.doi.org/10.1016/j.psyneuen.2013.03.007.
Udina M(1), Navinés R, Capuron L, Martín-Santos R.
Author information:
(1)Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM,
Spain; Department of Psychiatry and Clinical Psychobiology, University of
Barcelona, Catalonia, Spain.
Comment on
Psychoneuroendocrinology. 2013 Sep;38(9):1803-13.
Psychoneuroendocrinology. 2013 Sep;38(9):1829-30.
DOI: 10.1016/j.psyneuen.2013.05.019
PMID: 23810434 [Indexed for MEDLINE]